Article

Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein.

Protein Engineering Network Centres of Excellence, University of Toronto, Ontario, Canada.
Nature (Impact Factor: 42.35). 04/1995; 374(6521):477-9. DOI: 10.1038/374477a0
Source: PubMed

ABSTRACT Many signal transduction processes are mediated by the binding of Scr-homology-2 (SH2) domains to phosphotyrosine (pTyr)-containing proteins. Although most SH2-pTyr interactions occur between two different types of molecules, some appear to involve only a single molecular type. It has been proposed that the enzymatic activity and substrate recognition of the Src-family kinases, and the protein-binding and transforming activity of Crk-family adaptor proteins, are regulated by intramolecular SH2-pTyr interactions. In addition, the DNA-binding activity of Stat transcription factors seems to be regulated by SH2-mediated homodimerization. Here we examine the phosphorylated and non-phosphorylated forms of murine Crk II (p-mCrk and mCrk, respectively) using a combination of physical techniques. The Crk protein contains a single SH2 domain and two SH3 domains in the order SH2-SH3-SH3. There is a tyrosine-phosphorylation site between the two SH3 domains at residue 221 which is phosphorylated in vivo by the Abl tyrosine kinase. Using NMR spectroscopic analysis, we show here that the SH2 domain of purified p-mCrk is bound to pTyr, and by hydrodynamic measurements that the phosphorylated protein is monomeric. These results provide direct demonstration of an intramolecular SH2-pTyr interaction in a signalling molecule.

0 Bookmarks
 · 
58 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The signaling protein CrkII switches between forms with high or low binding affinity. Phosphorylation and native-state prolyl isomerization were both suggested to regulate the transition between these forms. Here we analyzed how phosphorylation at Tyr222 and Tyr252, and the Pro238Ala substitution affect signal transfer of human and chicken CrkII to a downstream target. Human CrkII is regulated by phosphorylation only, chicken CrkII by Pro238 trans→cis isomerization as well as by Tyr222 phosphorylation. Surprisingly, they act in an independent fashion. Apparently, the allosteric transition to a low-activity form can be induced by phosphorylation or prolyl isomerization located at distant sites in CrkII.
    Journal of Molecular Biology 10/2014; 426(24). DOI:10.1016/j.jmb.2014.09.022 · 3.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Prolyl cis/trans isomerizations have long been known as critical and rate-limiting steps in protein folding. More recently, it became clear that they are also used as slow conformational switches and molecular timers in the regulation of protein activity. Here we describe several such proline switches, how they are regulated and how prolyl isomerizations can function as attenuators and provide allosteric systems with a molecular memory. This article is part of a Special Issue entitled Proline-directed Foldases: Cell Signaling Catalysts and Drug Targets.
    Biochimica et Biophysica Acta (BBA) - General Subjects 12/2014; DOI:10.1016/j.bbagen.2014.12.019 · 3.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The molecular coupling of CAS and Crk in response to integrin activation is an evolutionary conserved signaling module that controls cell proliferation, survival and migration. However, when deregulated, CAS/Crk signaling also contributes to cancer progression and developmental defects in humans. Here we highlight recent advances in our understanding of how CAS/Crk complexes assemble in cells to modulate the actin cytoskeleton, and the molecular mechanisms that regulate this process. We discuss in detail the spatiotemporal dynamics of CAS/Crk assembly and how this scaffold recruits specific effector proteins that couple integrin signaling networks to the migration machinery of cells. We also highlight the importance of CAS/Crk signaling in the dual regulation of cell migration and survival mechanisms that operate in invasive cells during development and pathological conditions associated with cancer metastasis.
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 05/2004; DOI:10.1016/S0167-4889(04)00093-X · 5.30 Impact Factor